Cronos Group (CRON) Expected to Post Earnings on Thursday

Key Points

• Cronos Group is expected to report Q3 2026 earnings before market open on November 5. Analysts forecast earnings of $0.03 per share and revenue of $51.15 million; the earnings call is scheduled for 8:30 a.m. ET.
• The company’s previous quarter exceeded expectations, with EPS of $0.09 versus a $0.01 consensus estimate and revenue of $53.01 million versus $44.20 million expected.
• Analysts maintain a consensus “Buy” rating—including recent upgrades from Weiss Ratings and Zacks Research—though the average price target of $2.30 is below the stock’s reported $3.35 opening price.

Cronos Group (NASDAQ:CRON - Get Free Report) is expected to release its Q3 2026 results before the market opens on Thursday, November 5th. Analysts expect the company to post earnings of $0.03 per share and revenue of $51.15 million for the quarter. Individuals are encouraged to explore the company's upcoming Q3 2026 earnings results page for the latest details on the call scheduled for Thursday, November 5, 2026 at 8:30 AM ET.

Cronos Group (NASDAQ:CRON - Get Free Report) last released its earnings results on Thursday, August 6th. The company reported $0.09 EPS for the quarter, beating the consensus estimate of $0.01 by $0.08. Cronos Group had a net margin of 39.08% and a return on equity of 4.85%. The firm had revenue of $53.01 million for the quarter, compared to analysts' expectations of $44.20 million. On average, analysts expect Cronos Group to post $0.12 EPS for the current fiscal year and $0.25 EPS for the next fiscal year.

Cronos Group Trading Down 0.9%

Shares of Cronos Group stock opened at $3.35 on Thursday. Cronos Group has a 52 week low of $2.28 and a 52 week high of $3.61. The stock has a market cap of $1.23 billion, a PE ratio of 16.75 and a beta of 0.90. The company's 50-day moving average price is $3.30 and its two-hundred day moving average price is $2.85.

Analyst Ratings Changes

CRON has been the topic of a number of research analyst reports. Weiss Ratings upgraded Cronos Group from a "buy (b-)" rating to a "buy (b)" rating in a report on Thursday, October 8th. Wall Street Zen downgraded Cronos Group from a "buy" rating to a "hold" rating in a research note on Saturday, August 15th. Zacks Research upgraded Cronos Group from a "hold" rating to a "strong-buy" rating in a research report on Thursday, October 22nd. Finally, TD Securities restated a "buy" rating on shares of Cronos Group in a research report on Monday, September 28th. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat, Cronos Group currently has a consensus rating of "Buy" and an average target price of $2.30.

About Cronos Group

Cronos Group Inc is a Canadian cannabinoid company focused on developing, producing and commercializing cannabis and cannabis-derived consumer products. The company serves adult-use and medical cannabis markets through a portfolio of brands and sells products such as dried flower, pre-rolls, vaporizers, edibles, oils and other cannabis formats, subject to applicable regulations.

Its brand portfolio has included Spinach, which is positioned primarily in the adult-use cannabis market, as well as Lord Jones and PEACE NATURALS.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.